v3.26.3
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2026
Equity Controlling Interest  
Schedule of Common Stock

Conversion of debt to equity  62,586 
Granted in lieu of cash   658,799 
Direct placement of common stock   349,980 
Sales of common stock to public investors   525,926 
Issued for acquisition   352,207 
Issued under stock purchase agreement   300,680 
Total  2,250,178 
Schedule of Common Stock Warrants

           Weighted     
       Weighted   Average     
       Average   Remaining   Aggregate 
   Number of   Exercise   Contractual   Intrinsic 
   Shares   Price   Life (years)   Value 
Outstanding at December 31, 2025   60,193   $50.45    2.0   $2,742,015 
Granted   -    -    -    - 
Exercised   (60,173)   -    -    (2,741,045) 
Forfeited/cancelled   (327)  $30.40    -    - 

Outstanding at March 31, 2026

   21   $2,128.11    2.0    970 
Granted   -     -           
Exercised   -     -          -  
Forfeited/cancelled   -     -          -  
Outstanding at June 30, 2026   21    $2,128.11    

1.5

   $-